Averion International Corp. (fka AVRO)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Monksdream PremiumMember

03/16/24 1:48 PM

Post #22

AVRO under $2

Monksdream PremiumMember

02/20/24 4:20 AM

Post #21

AVRO under $2

Monksdream PremiumMember

10/01/23 4:25 PM

Post #20

AVRO under $2

The Night Stalker Free

05/28/23 1:36 AM

Post #19

Re: #16: @The Night Stalker - holding up well unlike my DRMA.........

wow

The Night Stalker Free

05/28/23 1:36 AM

Post #18

Re: #16: @The Night Stalker - holding up well unlike my DRMA.........

wow

MiamiGent

05/24/23 9:54 AM

Post #17

Re: #16: @The Night Stalker - holding up well unlike my DRMA.........

AVRO Yes, it is. Impressive pop yesterday, too.

The Night Stalker Free

05/23/23 11:02 PM

Post #16

Re: #14: @MiamiGent - AVRO Chart https://stockcharts.com/h-sc/ui?s=AVRO

holding up well unlike my DRMA.........

MiamiGent

05/23/23 8:18 AM

Post #15

AVRO "This transaction strengthens AVROBIO's balance sheet, focuses our pipeline strategy and is a strong endorsement of our HSC gene therapy approach and plato® gene therapy platform," AVRO's chief executive Erik Ostrowski remarked.

MiamiGent

05/23/23 8:15 AM

Post #14

Re: #13: @MiamiGent - AVRO Avrobio Stock Jumps On Sale Of Gene

AVRO Chart https://stockcharts.com/h-sc/ui?s=AVRO

MiamiGent

05/23/23 8:11 AM

Post #13

AVRO Avrobio Stock Jumps On Sale Of Gene Therapy Program To Novartis
BENZINGA
3:58 PM ET May-22-2023
Shares of clinical-stage gene therapy company AVROBIO, Inc. (NASDAQ:AVRO) are trading higher Monday due to its agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program for the treatment of cystinosis to Novartis AG (NYSE:NVS).

The Details: Avrobio agreed to sell the program to Novartis for $87.5 million in cash. The gene therapy company will retain full rights to its portfolio of first-in-class HSC gene therapies for Gaucher disease type 1 and type 3, Hunter syndrome and Pompe disease. (con't)

alchemytrader Free

05/22/23 10:10 AM

Post #12

Re: #11: @The Night Stalker - good for swing

1.48 now. congrats.

The Night Stalker Free

05/19/23 4:15 PM

Post #11

Re: #10: @conix - AVRO Chart

good for swing

conix

02/09/23 12:27 AM

Post #10

Re: #9: @ClayTrader - * * $AVRO Video Chart 07-15-2019 * *

AVRO Chart

ClayTrader Free

07/15/19 11:24 PM

Post #9

* * $AVRO Video Chart 07-15-2019 * *

Link to Video - click here to watch the technical chart video

RULiquid

03/02/11 2:13 PM

Post #8

avroenergy@gmail.com another email...just sent

vegaseagle Free

10/19/10 11:05 PM

Post #7

Re: #6: @prado - Pretty interesting PR from the AVRO website vegas.

Great job Prado!!!

prado

10/19/10 10:09 PM

Post #6

Re: #3: @vegaseagle - Good question

Pretty interesting PR from the AVRO website vegas. Looks like they merged together with 3 other companies and now have some serious money guys involved.

http://www.averionintl.com/uploadedFiles/News_and_Events/Press_Releases/Averion%20Merger%20Press%20Release_Ltrh_9Sept2010.pdf

I also copied this clip from the company website:

"Today, Averion is a leading CRO with a 25+ year history in supporting clinical trials for its clients. The Company now has over 400 professionals working in 14 countries."

http://www.averionintl.com/

@-@

09/16/10 6:26 PM

Post #5

Re: #4: @retireat40 - Evidently a quick P&D. Ran to .022 and

No news. I wonder if they're truly bagholders?

retireat40 Free

09/16/10 4:10 PM

Post #4

Re: #2: @@-@ - So what will become of AVNO?

Evidently a quick P&D. Ran to .022 and right back to .005. Many new bagholders here.

vegaseagle Free

09/15/10 3:33 PM

Post #3

Good question

@-@

02/10/10 6:36 PM

Post #2

Re: #1: @@-@ - TODAY ONLY

So what will become of AVNO?

@-@

01/06/10 3:16 PM

Post #1

TODAY ONLY

If you buy 20499 shares of AVNO you will get a cash out of .01 per share. If you buy at .006, you will make about $70.

Warning: Some brokers will charge you between $5 and $20 for the dividend/corporate action.

People with over 20500 will not receive a cash out. They will keep their shares.

Averion International Corp. (fka AVRO)

Followers	2	Posters	11
Posts (Today)	0	Posts (Total)	22
Created	01/06/10	Type	Free
Moderators

Averion International Corp. 225 Turnpike Road Southborough, MA 01772 Phone: 508-597-6000 OTC Market Tier Pink Sheets Current Primary SIC — Industry Classification 8731 - Commercial physical research State Of Incorporation DE Jurisdiction Of Incorporation United States Company Officers Markus Weissbach, Executive Chairman Philip T. Lavin, Vice Chairman, Founder James H. McGuire, Dir. Peter C. Gonze, President Lawrence R. Hoffman, CFO SEC Reporting Status De-Registered as of Dec 15, 2009 CIK 0001193940 Fiscal Year End 12/31 Estimated Market Cap $2,540,096 as of Jan 5, 2010 Outstanding Shares 635,024,122 as of Aug 4, 2008 Number of Shareholders of Record 41 as of Mar 31, 2008 Current Capital Change shs increased by 3 for 1 split Ex-Date: Mar 15, 2004 Record Date: Mar 12, 2004 Pay Date: Mar 12, 2004 Company Notes ◦Formerly=IT&E International Group, Inc. until 9-06 ◦Formerly=IT&E International Group until 3-06. State of Incorporation Nevada changed to Delaware concurrent with name change ◦Formerly=Clinical Trials

Board Info

Posts Today	0
Posts (Total)	22
Posters	11
Moderators

New Post

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Averion International Corp. (fka AVRO)

Averion International Corp. (fka AVRO)

Join the InvestorsHub Community

Averion International Corp. (fka AVRO)

Board Info